{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362825895333604736.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/0002-9343(91)90506-s"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:000293439190506S?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:000293439190506S?httpAccept=text/plain"}}],"dc:title":[{"@value":"Association of psychiatric manifestations with antibodies to ribosomal p proteins in systemic lupus erythematosus"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382825895333604740","@type":"Researcher","foaf:name":[{"@value":"Andrea B. Schneebaum"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895333604741","@type":"Researcher","foaf:name":[{"@value":"James D. Singleton"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895333604742","@type":"Researcher","foaf:name":[{"@value":"Sterling G. West"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895333604738","@type":"Researcher","foaf:name":[{"@value":"James K. Blodgett"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895333604736","@type":"Researcher","foaf:name":[{"@value":"Lisa G. Allen"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895333604737","@type":"Researcher","foaf:name":[{"@value":"John C. Cheronis"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895333604739","@type":"Researcher","foaf:name":[{"@value":"Brian L. Kotzin"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00029343"}],"prism:publicationName":[{"@value":"The American Journal of Medicine"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"1991-01","prism:volume":"90","prism:number":"1","prism:startingPage":"54","prism:endingPage":"62"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:000293439190506S?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:000293439190506S?httpAccept=text/plain"}],"createdAt":"2004-06-16","modifiedAt":"2025-09-03","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1390282681283219072","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"ANTI-RIBOSOMAL P ANTIBODIES ARE ASSOCIATED WITH NEPHRITIS, VASCULAR THROMBOSIS AND LYMPHOCYTOPENIA IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS"}]},{"@id":"https://cir.nii.ac.jp/crid/2051151842050499840","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Anti-ribosomal P antibodies and lupus nephritis"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/0002-9343(91)90506-s"},{"@type":"CROSSREF","@value":"10.5387/fms.51.11_references_DOI_88vnwZbOYQWG2TCzsLYl5xWFVTU"},{"@type":"CROSSREF","@value":"10.1007/s10157-011-0462-9_references_DOI_88vnwZbOYQWG2TCzsLYl5xWFVTU"}]}